Literature DB >> 1717558

Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences.

R Hakem1, P Le Bouteiller, A Jezo-Bremond, K Harper, D Campese, F A Lemonnier.   

Abstract

The transcription of HLA-A3 and HLA-B7 class I genes is differentially regulated by IFN-alpha and -gamma, the latter gene being more inducible than the former. To determine the structural basis of this differential response, hybrid genes were constructed in which complete or fragmented HLA-A3 or HLA-B7 promoters were fused to the chloramphenicol acetyl transferase coding sequence. These constructs were tested in transient transfection assays, and the differential response of the HLA-A3 and HLA-B7 genes to IFN was correlated with nucleotide differences in their interferon response sequences (IRS). Replacement of two T nucleotides in the HLA-A3 IRS by the homologous A and C nucleotides of the HLA-B7 IRS was sufficient to impart IFN inducibility of the HLA-A3 promoter and efficient binding of constitutive and IFN-induced nuclear factors to the IRS of HLA-A3. Since the same two nucleotide differences are shared by all sequenced HLA-A and HLA-B genes, these results suggest that high or low responsiveness to IFN might be a locus-related property.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717558

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC).

Authors:  K J Palmer; M Harries; M E Gore; M K Collins
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Potential regulatory sequences in the untranslated regions of the baboon MHC class Ib gene, Paan-AG, more closely resemble those in the human MHC class Ia genes than those in the class Ib gene, HLA-G.

Authors:  Daudi K Langat; Pedro J Morales; Asgerally T Fazleabas; Joan S Hunt
Journal:  Immunogenetics       Date:  2004-11-17       Impact factor: 2.846

4.  An HLA-B regulatory element binds a factor immunologically related to the upstream stimulation factor.

Authors:  J Girdlestone
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Potential role of NF-kB and RXR beta like proteins in interferon induced HLA class I and beta globin gene transcription in K562 erythroleukaemia cells.

Authors:  C K Moitreyee; A Suraksha; A S Swarup
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

Review 6.  Molecular evolution of elements controlling HLA-C expression: Adaptation to a role as a killer-cell immunoglobulin-like receptor ligand regulating natural killer cell function.

Authors:  Stephen K Anderson
Journal:  HLA       Date:  2018-11       Impact factor: 4.513

7.  Sequence polymorphism in the HLA-B promoter region.

Authors:  Z Yao; A Volgger; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors.

Authors:  J Girdlestone; M Isamat; D Gewert; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors.

Authors:  Adiba Isa; Jan O Nehlin; Hardee J Sabir; Tom E Andersen; Michael Gaster; Moustapha Kassem; Torben Barington
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.

Authors:  F M Marincola; P Shamamian; T B Simonis; A Abati; J Hackett; T O'Dea; P Fetsch; J Yannelli; N P Restifo; J J Mulé
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.